BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29306176)

  • 1. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
    van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
    Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and diagnostic outcome of bilateral recall at screening mammography.
    Lameijer JRC; Nederend J; Voogd AC; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2021 Jan; 148(1):48-56. PubMed ID: 32621785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
    Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
    Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
    Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
    van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.
    Kim JY; Cho N; Koo HR; Yi A; Kim WH; Lee SH; Chang JM; Han W; Moon HG; Im SA; Noh DY; Moon WK
    Radiology; 2013 Apr; 267(1):57-66. PubMed ID: 23329656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral breast cancer: early detection with mammography.
    Roubidoux MA; Helvie MA; Lai NE; Paramagul C
    Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
    Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
    Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography.
    Coolen AMP; Lameijer JRC; Voogd AC; Louwman MWJ; Strobbe LJ; Tjan-Heijnen VCG; Duijm LEM
    Eur Radiol; 2019 Jan; 29(1):337-344. PubMed ID: 29943181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study.
    Luiten JD; Korte B; Voogd AC; Vreuls W; Luiten EJT; Strobbe LJ; Rutten MJCM; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2019 Nov; 145(10):2720-2727. PubMed ID: 31001821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.
    Lameijer JRC; Coolen AM; Voogd AC; Strobbe LJ; Louwman MWJ; Venderink D; Tjan-Heijnen VC; Duijm LEM
    Eur Radiol; 2018 Oct; 28(10):4205-4214. PubMed ID: 29666991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.